Management Team

Michael W. Nall

President and Chief Executive Officer

Mr. Nall has more than 25 years of healthcare sales and marketing experience, most recently serving at Clarient Diagnostic Services, Inc. Prior to joining Clarient, Mr. Nall served in the diagnostic and medical device industries in various commercial leadership roles for companies including Impath, American Cyanamid, Maquet Surgical, Strato Medical, Horizon Medical Products and Columbia Vital Systems.

Mr. Nall received a Bachelor of Science degree in Business Administration from Central Missouri State University (now known as the University of Central Missouri).


Tim Kennedy

Chief Financial Officer and Senior Vice President of Operations

Mr. Kennedy brings more than 30 years of financial and operational leadership experience, including over 25 years in the clinical diagnostics industry. Most recently, Mr. Kennedy served as Chief Financial Officer of Millennium Health, a privately held leading urine drug testing and pharmacogenetics laboratory company. Prior to Millennium, he held various leadership positions are leading companies, such as PLUS Diagnostics, Diagnostic Imaging Management and National Health Laboratories.

Mr. Kennedy holds a bachelor’s degree in Business – Accounting/Information Technology from Keane University.


Lyle Arnold, Ph.D.

Senior Vice President of Research & Development and Chief Scientific Officer

Dr. Arnold is a biotechnology executive, entrepreneur and developer of innovative technologies covering therapeutics, molecular diagnostics, and genomics. The author of more than 50 scientific publications, he is the principal inventor of the chemiluminescent Hybridization Protection Assay (HPA) and associated technologies. Dr. Arnold holds 36 issued U.S. patents and more than 140 issued and pending patents worldwide. Prior to joining Biocept, Dr. Arnold has worked for various companies in the clinical and diagnostics space, including Aegea Biotechnologies, Gen-Probe, Molecular Biosystems (co-founder), Genta, Synteni, Incyte Genomics, Oasis Biosciences and UCSD Cancer Center.

He received a B.S. in Chemistry from the University of California at Los Angeles and a Ph.D. in Chemistry/Biochemistry from the University of California at San Diego.


Michael Terry

Senior Vice President Commercial Operations

A seasoned veteran in the molecular diagnostics and liquid biopsy industries, Mr. Terry has vast leadership experience managing large and small commercial teams. Prior to Biocept, he served as Executive Vice President of Sequenom, Inc., and more recently Trovagene, Inc. He also has held leadership positions at GE Healthcare’s Marquette Medical division, Lumenis Ltd, Aspect Medical Systems Inc. and Ligand Diagnostics.

Mr. Terry earned a BS in Economics and Business from the University of Wisconsin – Madison.


Michael W. Brown

General Counsel, Compliance and Privacy Officer

Mr. Brown has more than 20 years of experience in providing legal, compliance and privacy advice to healthcare companies, including Clarient Diagnostic Services, Inc. (a GE Healthcare Company), Edwards Lifescience, InSight Health Services Corp. and Apria Healthcare. In addition, Mr. Brown has been involved in negotiating settlements with the Office of Inspector General, establishing compliance and contracting programs and is a national speaker on healthcare, compliance, privacy and corruption. In 2009, Mr. Brown served on the Medical Device and Diagnostic Compliance Committee for AdvaMed revising the current Code of Ethics for the medical device industry.

Mr. Brown received his law degree from Pepperdine University School of Law and a Bachelor of Arts degree (cum laude) in Political Science from California State University at Fullerton.


David Moskowitz

Vice President of Strategy and Corporate Communications

Mr. Moskowitz coordinates the Company’s Investor Communications and Public Relations activities, and plays a key role in developing and driving Biocept’s value creation strategy. Prior to joining Biocept, he was Vice President, Investor Relations at Trovagene. Mr. Moskowitz spent most of his career as a leading equity research analyst, with more-than 16 years of Wall Street experience covering large-cap pharmaceutical, specialty pharmaceutical, biotechnology, generic drug, and molecular diagnostics companies.

He earned his BS in Pharmacy from Rutgers University, and his MBA in Finance and Pharmaceutical Industry Studies at Fairleigh Dickinson University.


Amy McNeal

Vice President Reimbursement Strategies

Ms. McNeal has more than 20 years of experience in the diagnostic laboratory industry where she has held leadership roles in both sales and business development. During the past eight years, she has focused on developing and implementing reimbursement strategies and managed care contracting. Prior to Biocept she held various positions with Clarient (a GE Healthcare Company), Pathology, Inc., Quest Diagnostics and LabCorp.

Ms. McNeal holds an MBA from Pepperdine University, Malibu, California and a Bachelor’s degree from Cal State, San Bernardino.


Cory Cairns

National Sales Director

Mr. Cairns brings 15 years of cancer diagnostics experience to Biocept. He most recently served as Sales Director at Integrated Diagnostics, and has held previous leadership positions with multiple companies in the diagnostics industry, including LabCorp, US Labs and Pathwork Diagnostics. Mr. Cairns leads Biocept’s US Sales and Customer Service teams, and is passionate about leadership and motivation, with prior experience as a personal coach.

He graduated from Emporia State University with a degree in Business Administration.


partner with biocept

Contact us to learn how Biocept can support your research and testing.

1.888.332.7729